#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia B without inhibitors Acute leukaemia Renal disorder Ependymoma Epilepsy Hypochromic anaemia Glomerulonephritis minimal lesion Non-Hodgkin's lymphoma unspecified histology indolent Immune thrombocytopenia Amyotrophic lateral sclerosis gene carrier Waldenstrom's macroglobulinaemia recurrent Synovial sarcoma Frostbite Homocystinuria Philadelphia chromosome positive More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Treatment Progressive multifocal leukoencephalopathy – Basic Information Hereditary hypophosphataemic rickets – Trials in Disease Von Willebrand’s disease – Life with Disease Pituitary-dependent Cushing’s syndrome Waldenstrom’s macroglobulinaemia – Trials in Disease Biotinidase deficiency – Life with Disease Angiosarcoma metastatic Glomerulonephritis membranous – Treatment Hypereosinophilic syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Doxycycline Pseudoephedrine Hydrochloride MB-001 Betahistine Dihydrochloride Clavulanic Acid Vib1116 Siltuximab Sertindole Cx-037231 Paliperidone Sodium Glycocholate ANUMIGILIMAB Vinblastine Sulfate Benfotiamine Iohexol Linaclotide Alxn1850 Mosliciguat HSP-CAR30 HAFNIUM OXIDE More therapies…

    Learn about Your Condition

    Bronchitis Exudative retinopathy HER2 positive gastric cancer Paraganglion neoplasm Vertigo Osteoporosis Compulsive sexual behaviour Autism spectrum disorder Diabetic autonomic neuropathy Gaucher's disease type I Oxygen saturation Thalassaemia Guttate psoriasis Anaemia of pregnancy Cardiomyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Juvenile psoriatic arthritis

  • Study on the Effects of Risankizumab and Adalimumab in Children with Active Juvenile Psoriatic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    Investigated Drugs:
    • Risankizumab
    • Adalimumab
    France Germany Italy Poland Spain

  • Study on the Long-term Safety of Guselkumab for Children with Crohn’s Disease, Ulcerative Colitis, or Juvenile Psoriatic Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Guselkumab
    Belgium France Germany Italy Norway Poland +2

  • Study on the Safety and Body Processing of Bimekizumab in Children with Juvenile Idiopathic Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Juvenile spondyloarthritis
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Bimekizumab
    France Germany Poland Spain

  • Study on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Guselkumab
    • Ustekinumab
    Denmark France Germany Italy The Netherlands Poland +1

  • Study of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Juvenile spondyloarthritis
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Ixekizumab
    • Adalimumab
    Belgium Czechia France Germany Italy The Netherlands +1

  • Study on Long-term Safety of Ustekinumab for Children with Crohn’s Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Ustekinumab
    Belgium France Germany Hungary Italy Poland +1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!